Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ciphergen Biosystems, Inc.
Proteomic analysis of circulating platelets can help with early cancer diagnosis
January 9th, 2005
Scientists at the Children's Hospital Boston, working in collaboration with scientists from Ciphergen Biosystems, Inc., (NASDAQ:CIPH), presented results at the American Society for Hematology 46th Annual Meeting in San Diego that suggest that proteomic analysis of circulating platelets can potentially be useful for early cancer diagnosis. Principal authors of the study, Dr.Giannoula Klement and Dr.Judah Folkman, state in their abstract: ..".using SELDI-TOF-mass spectrometry of platelet extracts, we have found that this novel property of platelets detects human cancers of a microscopic size undetectable by any presently available diagnostic method. The platelet...
Source: Aging & Elder Health Week (2005-01-09)
|
